Atossa Therapeutics (ATOS) Issues Letter to Shareholders

Go back to Atossa Therapeutics (ATOS) Issues Letter to Shareholders

Atossa Therapeutics Issues Letter to Shareholders Highlighting 2024 Accomplishments and Outlook for 2025

January 23, 2025 8:15 AM EST

SEATTLE, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or... More